Can You Drink Alcohol on Jardiance (Empagliflozin)?
Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 16th, 2026.
Published on July 15th, 2026. Updated on July 16th, 2026.
Key takeaways
Both alcohol and empagliflozin independently lower blood sugar, making hypoglycemia more likely when they are combined, especially on an empty stomach.
Empagliflozin carries a known risk of euglycemic DKA, and alcohol raises ketone levels on its own, meaning the two together can accelerate dangerous ketone buildup.
Both substances increase fluid loss through different mechanisms, so dehydration can develop faster than most patients expect.
Moderate drinking with a carbohydrate-containing meal and extra hydration is lower risk than drinking on an empty stomach or binge drinking.
Individual factors like kidney function, A1C control, and drinking habits all change your personal risk level, so personalized medical guidance matters before you choose to drink.
What Empagliflozin Does in the Body
Empagliflozin belongs to a class of medications called SGLT2 inhibitors. It works by instructing the kidneys to filter out excess glucose and excrete it through urine rather than reabsorbing it into the bloodstream. This mechanism consistently lowers blood sugar without relying on insulin, which is part of what makes it so useful for type 2 diabetes.
Beyond blood sugar control, empagliflozin is now approved for heart failure and chronic kidney disease as well, reflecting how broadly it affects cardiovascular and kidney function. As a side effect of its glucose-dumping mechanism, it also causes a mild reduction in blood pressure and a noticeable increase in urination. Both of those effects become clinically important when alcohol enters the picture.
How Alcohol Interacts With Empagliflozin
Alcohol is not a neutral beverage where diabetes medications are concerned. It independently lowers blood sugar, particularly when consumed on an empty stomach, and it interferes with the liver's ability to release stored glucose when the body needs it most. This means that when alcohol and empagliflozin are combined, their blood-sugar-lowering effects may stack in ways that push glucose to unexpectedly low levels.
The dehydration angle is equally important and often overlooked. Empagliflozin increases urination as a core part of how it works. Alcohol is also a diuretic, promoting fluid loss through a separate hormonal mechanism. When both are present, fluid depletion can accelerate faster than either substance would cause alone, raising the risk of symptoms like lightheadedness, rapid heartbeat, and dark concentrated urine.
Finally, alcohol can blur the cognitive and physical warning signs of hypoglycemia. Dizziness, confusion, and shakiness, which are all classic low blood sugar signals, are also common effects of alcohol itself, making it harder for a patient to recognize that something medically serious may be happening.
The DKA Risk Most Patients Are Not Warned About
Diabetic ketoacidosis (DKA) is traditionally associated with type 1 diabetes and severely elevated blood sugar. Empagliflozin introduces a different version called euglycemic DKA, where dangerous ketone buildup occurs even when blood glucose readings appear relatively normal. This is one of the most underappreciated risks of SGLT2 inhibitors across the board.
Alcohol compounds this risk directly. The body produces ketones as a byproduct of alcohol metabolism, meaning that drinking independently raises ketone levels. When combined with empagliflozin's tendency to shift the body toward ketone production, the two together can accelerate ketone buildup significantly. Heavy or binge drinking is recognized as a specific trigger for DKA in SGLT2 inhibitor users, and this applies to type 2 diabetes patients who may never have experienced DKA before and may not think of themselves as being at risk.
Warning signs of DKA that patients should know include nausea, vomiting, abdominal pain, rapid or labored breathing, and a fruity or acetone smell on the breath. These symptoms require prompt medical evaluation and should not be dismissed as ordinary hangover effects.
Comparing Drinking Patterns and Their Risks
Not all drinking carries the same level of risk on empagliflozin. The following table outlines how occasional moderate drinking compares to heavy or binge drinking across the key risk factors.
Risk Factor |
Moderate Drinking (1 drink/day for women, 2 for men) |
Heavy or Binge Drinking (4+ drinks in a session) |
|---|---|---|
Hypoglycemia risk |
Mildly elevated, especially without food |
Significantly elevated, harder to detect and correct |
DKA risk |
Low to moderate with food and hydration |
High, recognized trigger for euglycemic DKA in SGLT2 users |
Dehydration risk |
Manageable with adequate water intake |
Rapid and potentially severe |
Symptom recognition |
Generally preserved |
Impaired by alcohol's overlapping effects |
Blood glucose monitoring |
Recommended more frequently |
Critical and may still miss euglycemic DKA |
The core message here is that risk is not binary. Light, food-accompanied drinking with careful monitoring sits in a very different category than drinking heavily or drinking without eating first.
Practical Steps for Patients Who Choose to Drink
For patients who decide to have a drink while taking empagliflozin, a few practical habits can meaningfully reduce the layered risks involved.
Eating a carbohydrate-containing meal before or alongside alcohol helps buffer the blood sugar drops that occur when the liver is busy metabolizing alcohol instead of releasing stored glucose. Skipping food while drinking is one of the highest-risk behaviors in this combination.
Hydration matters more than many people realize on this medication. Drinking water before, during, and after alcohol consumption helps offset the combined diuretic effects of both substances. Setting a rough goal of one glass of water per alcoholic drink is a simple way to stay ahead of dehydration.
Blood glucose monitoring should happen more frequently on any day alcohol is consumed. Checking glucose before drinking, during the evening, and before bed gives a clearer picture of how the combination is affecting your numbers. Because euglycemic DKA can occur with normal-appearing glucose readings, monitoring blood sugar alone is not a complete safety net, but it remains a useful part of the picture.
Moderate drinking, defined as up to one drink per day for women and up to two for men, is generally considered lower risk than heavy or binge drinking. That said, no quantity of alcohol has been officially declared safe in combination with empagliflozin, and individual variation in kidney function, baseline glucose control, and personal alcohol metabolism means that what is manageable for one patient may not be for another.
When to Get Personalized Guidance Before You Drink
Some patients face elevated baseline risk that makes the alcohol and empagliflozin combination particularly worth discussing with a clinician before acting on. These include anyone with a prior DKA episode, frequent hypoglycemia, reduced kidney function, or a pattern of heavier drinking.
Timing this conversation before a holiday gathering, travel, or social event is far more useful than seeking care after an incident. Doctronic's free AI consultations, with 99.2% treatment plan alignment with board-certified physicians, are available 24/7 and allow patients to describe their full health picture, including their specific medications, kidney function, and typical drinking habits, to get guidance that reflects their actual situation rather than generic advice. Video visits with a clinician are available for $39 when a more formal consultation is needed. Having this conversation in advance is a straightforward way to reduce uncertainty and make a more informed personal choice.
Frequently Asked Questions
Yes, this combination may increase hypoglycemia risk. Alcohol independently lowers blood sugar, especially on an empty stomach, and it can impair the liver's ability to release stored glucose. When added to empagliflozin's glucose-lowering effect, blood sugar can drop further than expected, and alcohol may mask classic warning signs like dizziness and shakiness.
Heavy or binge drinking is a recognized trigger for euglycemic DKA in people taking SGLT2 inhibitors like empagliflozin. Alcohol raises ketone production on its own, and combined with empagliflozin's ketone-elevating mechanism, ketone buildup can accelerate quickly, even when blood sugar readings appear relatively normal. This risk applies to type 2 diabetes patients, not just type 1.
Light, moderate drinking with food and good hydration is generally considered lower risk than heavy drinking, but no amount of alcohol is officially declared completely safe with empagliflozin. Individual factors including kidney function, overall glucose control, and personal drinking tolerance all influence your actual risk. Checking with a clinician before drinking is the safest approach.
Do not skip or adjust your empagliflozin dose without speaking to your prescribing clinician first. Stopping the medication on your own may disrupt your glucose and cardiovascular management. Your doctor or a clinician through a telehealth service can give personalized guidance on whether any dose timing adjustments are appropriate for your specific situation.
Seek medical attention promptly if you experience nausea, vomiting, abdominal pain, rapid breathing, or fruity-smelling breath after drinking on empagliflozin. These may be signs of DKA, which can occur even when blood sugar appears normal. Do not wait to see if symptoms resolve on their own, as DKA can worsen quickly and requires prompt evaluation.
The Bottom Line
Drinking alcohol while taking Jardiance (empagliflozin) involves layered risks that many patients are never warned about at the pharmacy. Hypoglycemia, accelerated dehydration, and euglycemic DKA are all possible concerns, with DKA being the most underappreciated danger. Light, food-accompanied drinking with careful monitoring is far lower risk than binge drinking, but no amount is officially declared safe. Your personal risk depends on kidney function, glucose control, and drinking habits, which is exactly why personalized guidance matters. Doctronic offers free AI consultations with 99.2% treatment plan alignment with board-certified physicians, available 24/7, so you can get specific answers before your next social event rather than after an incident. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get diabetes care advice
Chat Now